Accommodations | Scientific Program | Sponsors and Exhibitors

Get Ready for ASV 2026!

ASV meetings are among the largest and most important virology conferences in the world. These meetings provide a forum to promote discussion and collaboration among scientists active in all aspects of virology, from basic research to vaccines and antiviral therapeutics. The meeting attracts 1400-1800 national and international scientists for a program crafted from over 1000 participant-submitted abstracts, 17 invited symposium speakers, and 6 distinctive State-of-the-Art speakers. Prior to the official start of the 2026 meeting, on July 27th, we will hold 4 special-topic satellite meetings that day, covering animal virology, prokaryotic virology, research experiences in industry, and evolution and ecology.

There are additional special events on techniques for classroom teaching, networking for new faculty, communications, and business concerns of the Society. Professional education workshops held at the ASV meetings provide a distinct focus on the career development needs of junior faculty, postdoctoral fellows, and graduate students, many of whom attend the meeting to network in search of academic, government, or corporate positions.

See the full ASV 2026 Scientific Program here.

Local Host Spotlight
Yuying Liang, PhD University of Minnesota – Twin Cities		Louis M. Mansky, PhD University of Minnesota – Twin Cities		Wei Zhang, PhD University of Minnesota – Twin Cities
The Liang lab focuses on both basic and translational research on arenaviruses, a family of enveloped RNA viruses with a bi-segmented genome that are carried by local rodents and can cause severe hemorrhagic fevers in humans.  Our research areas include studying virus-host interactions and developing a recombinant Pichindé virus (PICV) vector as a platform for vaccines and immunotherapies targeting animal and human diseases.		The Mansky research group has maintained long-standing interests in the replication, evolution, and virus-host cell interactions of the human retroviruses – human T-cell leukemia virus type 1 (HTLV-1) and human immunodeficiency virus types 1 and 2 (HIV-1, HIV-2). Areas of investigation have included the determinants of HIV-1 mutagenesis, lethal mutagenesis as an antiviral strategy, and the comparative analysis of HTLV and HIV particle assembly and host-cell interactions. Dr. Mansky is the founding director of the University of Minnesota’s Institute for Molecular Virology as well as the founding director of the NIH T32-supported Minnesota Training Program in Virology.		Dr. Zhang’s research group investigates structural transformations of enveloped viruses, including alphaviruses and retroviruses, during assembly and infection. We use cryo-EM, cryo-ET, and 3D reconstruction methods to elucidate how alphaviruses mediate membrane fusion during entry and the key determinants of retrovirus assembly and maturation. We aim to reveal structure-function relationships by resolving the atomic details of critical viral proteins involved in these essential biological processes.